Nasonov E, Fatenejad S, Feist E, Ivanova M, et al. Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study. Ann Rheum Dis 2021 Aug 3. pii: annrheumdis-2021-219876.
PMID: 34344706